English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 18034/20233 (89%)
造訪人次 : 23630750      線上人數 : 687
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/26556


    標題: 奈米載體包埋量子點於生物成像和抗癌治療上的劑型設計及評估
    Formulation design and evaluation of quantum dot-loaded nanocarriers for integrating bioimaging and anticancer therapy
    作者: 黃裕傑
    貢獻者: 藥物科技研究所
    許淑慧
    關鍵字: 奈米脂質結構載體
    微脂粒
    藥物傳輸
    抗癌
    量子點
    Anticancer
    Quantum dots
    Liposomes
    Nanostructured lipid carriers
    Drug delivery
    日期: 2012
    上傳時間: 2013-04-22 16:49:55 (UTC+8)
    摘要: 在此研究中,我們對於奈米劑型同時包覆抗癌藥物和量子點 (quantum dots, QDs) 之處方設計、生物成像和藥物傳遞做全面的探討,目的是為了整合診斷和治療。本實驗主要是探討兩種奈米劑型:奈米脂質結構載體 (nanostructured lipid carriers, NLCs) 和微脂粒 (liposomes)。奈米劑型的物化特性藉由測定粒徑大小、表面電位、形態學、分子環境、示差熱掃描分析儀 (differential scanning calorimetry, DSC) 和核磁共振 (nuclear magnetic resonance, NMR) 得知。對於奈米劑型在生物成像和藥物傳遞的應用上,分別評估了細胞毒性、細胞遷移、細胞攝入、在體內腫瘤即時監控和腫瘤累積藥物含量。首先選擇不同性質的量子點包埋於 NLCs 中,稱為 QDNLCs,包括脂溶性量子點 (L-QDs)、羧基功能修飾的量子點 (C-QDs) 和聚乙二醇修飾的量子點 (P-QDs)。對於黑色素癌細胞毒殺實驗經由奈米劑型包埋後是優於游離的 camptothecin。在生物成像實驗中,以C-QDNLCs 於腫瘤的螢光訊號可以維持至少 24 小時。在第二個部分則是研究以不同處方的微脂粒包埋 C-QDs。實驗結果發現帶正電微脂粒包埋 QDs 為最佳選擇,因為其具有藥物控釋能力,高腫瘤細胞毒殺能力,並具有顯著的細胞和實體腫瘤螢光標記。本研究評估包埋抗癌藥物和 QDs 的奈米劑型系統做為一種新的多功能載體,並能同時達到治療及診斷的目的且深具未來發展潛力。
    In this report, we comprehensively studied the formulation design, bioimaging, and delivery of drug-entrapped nanocarriers with quantum dots (QDs), for integrating diagnosis and therapy. This study is to use the two nanocarriers: nanostructured lipid carriers (NLCs) and liposomes. Nanocarriers were characterized by size, zeta potential, morphology, molecular environment, differential scanning calorimetry (DSC), and nuclear magnetic resonance (NMR). The application of the nanocarriers for imaging and drug delivery was evaluated by cytotoxicity, cell migration, cellular uptake, in vivo real-time tumor monitoring, anddrug accumulation in tumors. (Part I) Different QDs were selected to load with NLCs, which called QDNLC, including lipophilic QDs (L-QDs), carboxyl functioned QDs (C-QDs) and polyethylene glycol QDs (P-QDs). Cytotoxicity of the nanoparticles against melanoma cells was superior to that of free camptothecin. The real-time bioimaging demonstrated that C-QDNLCs could maintain the signaling in tumors for at least 24 h. (Part II) C-QDs was incorporated into different liposomes. Cationic quantum dot liposomes may be the best nanocarriers selected from this work because of their release, high cytotoxicity, and significant fluorescence labeling on cells and solid tumors. The drug-loaded nanocarriers with QDs evaluated in this study afford a new potential method for simultaneous therapeutic and diagnostic purposes.
    關聯: 校內外均一年後公開 ,學年度:100,131頁
    顯示於類別:[藥學系(所)] 博碩士論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    etd-0830112-112600.pdf6680KbAdobe PDF6174檢視/開啟
    index.html0KbHTML1檢視/開啟


    在CNU IR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋